S. 4839 is a bill that mandates the Board of Governors of the Federal Reserve System, the Comptroller of the Currency, and the Federal Deposit Insurance Corporation to conduct a study on the partnerships between financial technology (fintech) companies and traditional banking organizations. The goal of the study is to explore the implications and benefits of these collaborations in the financial sector.
Supporters of S. 4839 have praised the bill for promoting innovation in the financial sector. They argue that studying fintech and banking partnerships could lead to improved financial services for consumers and businesses, enhance competition, and drive economic growth. Advocates believe that understanding these relationships will help regulators create a more effective framework for overseeing the evolving landscape of finance.
Critics of S. 4839 have raised concerns about the potential risks associated with fintech and banking partnerships, including issues related to consumer data privacy, security, and regulatory oversight. Some media outlets have expressed skepticism about whether the study will lead to meaningful regulations or simply serve as a delay tactic that allows fintech companies to operate with less scrutiny.
The analysis of bill S. 4839, which focuses on the partnership between financial technology companies and banking organizations, shows no direct industry overlaps with the sponsor Pete Ricketts' top donor industries. While there is significant lobbying activity in the financial sector, the specific donors listed do not appear to have a direct financial interest in the bill's subject matter. The largest contributions come from companies like Vertex Pharmaceuticals and Frontier Infrastructure Holdings, which are not directly related to financial technology or banking. This lack of direct overlap suggests a low risk of conflict of interest, as the sponsor's financial backers are not positioned to benefit from the bill's provisions.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | MARSHALL & POPP, LLC | $60,000 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | MARSHALL & POPP, LLC | $60,000 |
| WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) | RED MAPLE CONSULTING, LLC | $40,000 |
| FRONTIER INFRASTRUCTURE HOLDINGS LLC | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| ECKERD CONNECTS | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| SMART APPROACHES TO MARIJUANA | OFF HILL STRATEGIES L.L.C. | $20,000 |
| FEDERATION OF ELECTRIC POWER COS OF JAPAN | GEORGE H. DENISON | $10,000 |
| MAYO CLINIC | MCDERMOTT WILL & SCHULTE LLP | undisclosed |
| VERIZON COMMUNICATIONS, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG TEN CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG 12 CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| SOUTHEASTERN CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| PAC-12 CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| ATLANTIC COAST CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| SAPPHIRE DIGITAL | MARSHALL & POPP, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Pete Ricketts, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
